Skip to main content
Clinical Trials/NCT05408143
NCT05408143
Recruiting
Not Applicable

An Enhanced Home-Based Telemedicine Program Using Remote Examination Devices for Children With Medical Complexity Receiving Comprehensive Care: a Single-Center Randomized Controlled Trial

The University of Texas Health Science Center, Houston1 site in 1 country300 target enrollmentJuly 12, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Diseases in Children
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
300
Locations
1
Primary Endpoint
Total number of episodes of serious illnesses (causing death, pediatric ICU admission, and hospital stay > 7d).
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to assess if the benefits for children with medical complexity (CMC) receiving comprehensive care (CC) in an enhanced medical home can be further improved by enhanced telemedicine program (ETM) provided during clinic hours using mobile devices to measure temperature& oxygen saturation, auscultate the heart & lungs, and view the skin, throat, & tympanic membranes in the home.

Registry
clinicaltrials.gov
Start Date
July 12, 2022
End Date
November 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ricardo A. Mosquera

Associate Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • Greater than or equal to 2 hospitalizations or greater than or equal to 1 ICU admission in the year before joining the comprehensive care program
  • Greater than 50 percent estimated risk of hospitalization without our care as judged by the medical director

Exclusion Criteria

  • Major heart disease
  • Mitochondrial disorders
  • Active cancer
  • Do-Not-Resuscitate (DNR) order
  • Patients receiving compassionate care

Outcomes

Primary Outcomes

Total number of episodes of serious illnesses (causing death, pediatric ICU admission, and hospital stay > 7d).

Time Frame: end of study(about 24 months)

Number of days care provided in a medical setting

Time Frame: end of study(about 24 months)

Secondary Outcomes

  • Cost effectiveness of ETM(end of study(about 24 months))
  • Total number of hospital days(end of study(about 24 months))
  • Total number of deaths(end of study(about 24 months))
  • Total number of emergency department visits(end of study(about 24 months))
  • Total numbers of clinic visits(end of study(about 24 months))
  • All cause infections on admission to the hospital(end of study(about 24 months))
  • Total number of Pediatric Intensive Care Unit (PICU) days(end of study(about 24 months))
  • Parent ratings of care assessed using the Consumer Assessment of Healthcare Providers and Systems Survey(end of study(about 24 months))

Study Sites (1)

Loading locations...

Similar Trials